Breast Cancer Clinical Trials

Showing 4421-4440 of 5,597 trials

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

NCT02662868

The purpose of this study is to describe demographics and socioeconomics characteristics associated to the diagnosis of metastatic breast cancer in Brazil.

Metastatic Breast Cancer

Latin American Cooperative Oncology Group767 participantsStarted Jun 2015

Fortaleza, Ceará, Brazil • Fortaleza, Ceará, Brazil • Salvador, Estado de Bahia, Brazil +21 more locations

COMPLETED

Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging

NCT01060085

The primary objective of this study is to compare the diagnostic accuracy of Digital Breast Tomosynthesis (DBT) versus that of Contrast Enhanced Magnetic Resonance Imaging (CEMRI) in determining the size of breast cancer preoperatively. Secondary objectives include: 1. Comparing the operating characteristics of each combined imaging protocol with respect to the reference standard, i.e. histopathologic assessment, of additional non-index lesions. 2. Comparison of re-excision rates based on estimated disease extent from adjunctive CEMRI vs. adjunctive DBT. 3. Evaluation of patient satisfaction with regard to the adjunctive modality (DBT vs. CEMRI).

Ductal Carcinoma In SituInvasive Breast Cancer

Dartmouth-Hitchcock Medical Center51 participantsStarted Feb 2009

Lebanon, New Hampshire, United States

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging

Related Searches

Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer

Avon Foundation Program to Improve Quality of Life in Breast Cancer Survivors

Physical Training on Patients With Breast Cancer

The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Safety of Xeloda in Solid Tumours

SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer

Physical Evaluation and Quality of Life in the Practice of Fencing in Breast Cancer Support

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer

A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer

Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer

Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver

Opting for Breast Reconstruction After Mastectomy or Not: Search for Influencing Factors